OxFORD Asset Management LLP acquired a new position in PAREXEL International Co. (NASDAQ:PRXL) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 33,126 shares of the medical research company’s stock, valued at approximately $2,918,000. OxFORD Asset Management LLP owned about 0.06% of PAREXEL International at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. BNP Paribas Arbitrage SA raised its stake in shares of PAREXEL International by 121.1% during the second quarter. BNP Paribas Arbitrage SA now owns 25,765 shares of the medical research company’s stock valued at $2,239,000 after acquiring an additional 14,110 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of PAREXEL International by 1,905.8% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 149,292 shares of the medical research company’s stock valued at $12,975,000 after acquiring an additional 141,849 shares in the last quarter. Wesbanco Bank Inc. raised its stake in shares of PAREXEL International by 12.0% during the second quarter. Wesbanco Bank Inc. now owns 34,068 shares of the medical research company’s stock valued at $2,961,000 after acquiring an additional 3,645 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of PAREXEL International by 1,008.1% during the second quarter. JPMorgan Chase & Co. now owns 982,186 shares of the medical research company’s stock valued at $85,362,000 after acquiring an additional 893,551 shares in the last quarter. Finally, Piedmont Investment Advisors LLC raised its stake in shares of PAREXEL International by 43.3% during the second quarter. Piedmont Investment Advisors LLC now owns 21,655 shares of the medical research company’s stock valued at $1,882,000 after acquiring an additional 6,543 shares in the last quarter. 87.45% of the stock is owned by institutional investors and hedge funds.
Separately, Zacks Investment Research raised shares of PAREXEL International from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a research note on Thursday, August 31st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $80.76.
PAREXEL International Co. (NASDAQ PRXL) opened at $88.08 on Friday. The company has a quick ratio of 1.45, a current ratio of 1.45 and a debt-to-equity ratio of 1.01. PAREXEL International Co. has a 1-year low of $51.16 and a 1-year high of $88.10.
COPYRIGHT VIOLATION NOTICE: “OxFORD Asset Management LLP Acquires Shares of 33,126 PAREXEL International Co. (PRXL)” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States and international trademark & copyright laws. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/12/10/oxford-asset-management-llp-acquires-shares-of-33126-parexel-international-co-prxl.html.
PAREXEL International Company Profile
PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.
Receive News & Ratings for PAREXEL International Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Co. and related companies with MarketBeat.com's FREE daily email newsletter.